These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1589 related items for PubMed ID: 26923792

  • 21. Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients.
    Schäfer A, Flierl U, Berliner D, Bauersachs J.
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):555-568. PubMed ID: 32350792
    [Abstract] [Full Text] [Related]

  • 22. Ninety-day prognosis of patients receiving direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: The real life evidence.
    Masotti L, Grifoni E, Dei A, Vannucchi V, Moroni F, Spolveri S, Panigada G, Landini G.
    Thromb Res; 2018 Dec; 172():165-168. PubMed ID: 30419471
    [No Abstract] [Full Text] [Related]

  • 23. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A, Lin T, Plesman J, Heeger CH, Lemes C, Metzner A, Mathew S, Wissner E, Wohlmuth P, Ouyang F, Kuck KH, Tilz RR.
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Current clinician perspective on non-vitamin K antagonist oral anticoagulant use in challenging clinical cases.
    Türk UÖ, Acar RD, Akgün T, Emren V, Kanat S, Karacağlar E, Kepez A, Kul Ş, Özel E, Şimşek E, Yakar Tülüce S, Tülüce K, Camm AJ.
    Turk Kardiyol Dern Ars; 2020 Apr; 48(3):289-303. PubMed ID: 32281950
    [Abstract] [Full Text] [Related]

  • 28. Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study.
    Sjögren V, Byström B, Renlund H, Svensson PJ, Oldgren J, Norrving B, Själander A.
    PLoS One; 2017 Apr; 12(7):e0181000. PubMed ID: 28700711
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life.
    Giustozzi M, Vedovati MC, Verdecchia P, Pierpaoli L, Verso M, Conti S, Cianella F, Marchesini E, Filippucci E, Agnelli G, Becattini C.
    Eur J Intern Med; 2016 Sep; 33():42-6. PubMed ID: 27394924
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of different oral anticoagulant regimens in patients with atrial fibrillation undergoing ablation or cardioversion.
    Gawałko M, Kapłon-Cieślicka A, Budnik M, Babiarz A, Bodys A, Uliński R, Żochowski M, Peller M, Scisło P, Kochanowski J, Filipiak KJ, Opolski G.
    Pol Arch Intern Med; 2017 Dec 22; 127(12):823-831. PubMed ID: 28972957
    [Abstract] [Full Text] [Related]

  • 33. A comparison between vitamin K antagonists and new oral anticoagulants.
    Jolobe OMP.
    Br J Clin Pharmacol; 2017 Nov 22; 83(11):2589-2590. PubMed ID: 28703392
    [No Abstract] [Full Text] [Related]

  • 34. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Hylek E, Kowey PR, Mahaffey KW, O'Brien EC, Singer DE, Peterson ED, Piccini JP, Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients.
    Am Heart J; 2017 Jul 22; 189():40-47. PubMed ID: 28625380
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data.
    Kohsaka S, Katada J, Saito K, Jenkins A, Li B, Mardekian J, Terayama Y.
    Open Heart; 2020 Jul 22; 7(1):e001232. PubMed ID: 32341789
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation.
    Okishige K, Nakamura T, Aoyagi H, Kawaguchi N, Yamashita M, Kurabayashi M, Suzuki H, Asano M, Shimura T, Yamauchi Y, Sasano T, Hirao K.
    J Cardiol; 2017 Jan 22; 69(1):11-15. PubMed ID: 27160710
    [Abstract] [Full Text] [Related]

  • 39. Comparative Effectiveness and Safety of Rivaroxaban in Adults With Nonvalvular Atrial Fibrillation.
    Aronow WS, Shamliyan TA.
    Am J Ther; 2019 Jan 22; 26(6):e679-e703. PubMed ID: 30461433
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 80.